Efficacy of peptide nucleic acid and selected conjugates against specific cellular pathologies of amyotrophic lateral sclerosis

Bioorg Med Chem. 2016 Apr 1;24(7):1520-7. doi: 10.1016/j.bmc.2016.02.022. Epub 2016 Feb 18.

Abstract

Cellular studies have been undertaken on a nonamer peptide nucleic acid (PNA) sequence, which binds to mRNA encoding superoxide dismutase 1, and a series of peptide nucleic acids conjugated to synthetic lipophilic vitamin analogs including a recently prepared menadione (vitamin K) analog. Reduction of both mutant superoxide dismutase 1 inclusion formation and endoplasmic reticulum stress, two of the key cellular pathological hallmarks in amyotrophic lateral sclerosis, by two of the prepared PNA oligomers is reported for the first time.

Keywords: Amyotrophic lateral sclerosis; Peptide nucleic acid; Vitamin conjugation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Amyotrophic Lateral Sclerosis / genetics
  • Amyotrophic Lateral Sclerosis / metabolism
  • Amyotrophic Lateral Sclerosis / pathology*
  • Animals
  • Cells, Cultured
  • Endoplasmic Reticulum Stress / drug effects*
  • Mice
  • Peptide Nucleic Acids / chemical synthesis
  • Peptide Nucleic Acids / chemistry
  • Peptide Nucleic Acids / pharmacology*
  • Superoxide Dismutase / deficiency
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / metabolism*
  • Superoxide Dismutase-1
  • Thermodynamics
  • Vitamins / chemistry
  • Vitamins / pharmacology*

Substances

  • Peptide Nucleic Acids
  • Vitamins
  • Superoxide Dismutase
  • Superoxide Dismutase-1